trading halt

Request for Trading Halt for Prana Biotechnology Limited
In accordance with ASX Listing Rule 17.1, the Directors of Prana Biotechnology Limited (“the
Company”) request an immediate trading halt in respect of its securities (ASX Code: PBT).
In requesting the trading halt, the Company provides the following information:
• The trading halt is necessary as the Company is preparing an announcement for the market
in relation to the results of its PBT2 IMAGINE Alzheimer’s Disease Phase II Trial;
• Unless otherwise requested by the Company, the Company requests the trading halt to
remain in place until the earlier of commencement of trade on Wednesday 2 April 2014, or
until the Company makes an announcement about the results of the Phase II Alzheimer’s
Disease Trial;
• The Company is not aware of any reason why the trading halt should not be granted or of
any other information necessary to inform the market about the trading halt.